US › Healthcare

Valion Bio Inc (VBIO)

US · Healthcare · Biotechnology

$0.51+1.57%

Last close · 2026-11-06

Latest quarter · ended 2026-06-30

Revenue

$1.1M

Revenue YoY

+1190.3%

Net profit

$-7.1M

EPS

$-2.17

Net margin

-640.1%

Key statistics

Market cap

$1.1M

Forward P/E

0.0

P/B

0.26

Book value

$25.57

EPS (TTM)

$-177.91

52-week high

$67.50

52-week low

$0.47

50-day MA

$2.04

200-day MA

$14.64

Beta

1.91

Shareholding

Insiders

0.26%

Institutions

5.12%

Largest institutional holders

Fund	Stake
Murchinson Ltd.	0.24%
Sanctuary Advisors, LLC	0.13%
Marex Group Ltd	0.11%
Virtu Financial LLC	0.08%
Geode Capital Management, LLC	0.04%
HRT FINANCIAL LLC	0.02%
UBS Group AG	0.02%
TWO SIGMA SECURITIES, LLC	0.02%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Valion Bio Inc — free to start.

Open in the app Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc Merck & Company Inc UnitedHealth Group Incorporated Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Gilead Sciences Inc Abbott Laboratories Novo Nordisk A/S

Data updated 2026-11-07.